Akili

📍 Boston, United States🗓 Founded 2011👥 189 employees💰 Last funded 2022
Biotechnology Research🌐 akiliinteractive.com
Website LinkedIn
Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! Were continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity/ disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases. And were always looking for game-changers to join our team – to help us change the status quo of medicine and ignite new hope for those living with cognitive deficits. Imagine what medicine can be®
11
Total investors
0
Early stage
2
Mid stage
8
Late stage
2011
Founded

Investors

11 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
8
Japan
2
Spain
1
Investor activity2014–2022 · investors recorded per year
2014120161201862021220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Akili?
Akili has 11 investors on record on gritt.io, 2 mid-stage and 8 late-stage investors.
When did Akili last raise funding?
The most recent investment in Akili recorded on gritt.io was in 2022.
When was Akili founded?
Akili was founded in 2011.
What industry is Akili in?
Akili operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Akili based?
Akili is headquartered in Boston, United States.